POTASSIUM, MONOBASIC for Ill-defined disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where POTASSIUM, MONOBASIC was used for Ill-defined disorder.
Most Reported Side Effects for POTASSIUM, MONOBASIC
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Condition aggravated | 38 | 25.5% | 20 | 5 |
| Respiratory failure | 35 | 23.5% | 20 | 4 |
| Off label use | 27 | 18.1% | 0 | 7 |
| Febrile neutropenia | 25 | 16.8% | 0 | 13 |
| Drug hypersensitivity | 21 | 14.1% | 0 | 1 |
| Toxic epidermal necrolysis | 20 | 13.4% | 0 | 0 |
| Product use in unapproved indication | 17 | 11.4% | 0 | 0 |
| Death | 16 | 10.7% | 16 | 1 |
| Drug ineffective | 14 | 9.4% | 0 | 8 |
| Macular degeneration | 14 | 9.4% | 0 | 8 |
| Pyrexia | 10 | 6.7% | 2 | 9 |
| Headache | 9 | 6.0% | 0 | 8 |
| Abdominal pain | 8 | 5.4% | 1 | 7 |
| Haematochezia | 8 | 5.4% | 1 | 7 |
| Malaise | 8 | 5.4% | 0 | 8 |
Other Indications for POTASSIUM, MONOBASIC
Other Drugs Used for Ill-defined disorder
IBUPROFEN (707)
ATORVASTATIN (570)
DAPAGLIFLOZIN (556)
SERTRALINE (437)
AMLODIPINE (415)
ROSUVASTATIN (361)
OMEPRAZOLE (272)
DOXYCYCLINE (254)
PREGABALIN (248)
LANSOPRAZOLE (227)